Open Access Articles- Top Results for CCR2


SymbolsCCR2 ; CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R
External IDsOMIM601267 MGI106185 HomoloGene537 IUPHAR: 59 GeneCards: CCR2 Gene
RefSeq (mRNA)NM_001123041NM_009915
RefSeq (protein)NP_001116513NP_034045
Location (UCSC)Chr 3:
46.4 – 46.4 Mb
Chr 9:
124.1 – 124.11 Mb
PubMed search[1][2]

C-C chemokine receptor type 2 (CCR2 or CD192 (cluster of differentiation 192) is a protein that in humans is encoded by the CCR2 gene.[1] CCR2 is a chemokine receptor.


This CCR2 gene is located in the chemokine receptor gene cluster region. Two alternatively spliced transcript variants are expressed by the gene.[1]


This gene encodes two isoforms of a receptor for monocyte chemoattractant protein-1 (CCL2), a chemokine which specifically mediates monocyte chemotaxis. Monocyte chemoattractant protein-1 is involved in monocyte infiltration in inflammatory diseases such as rheumatoid arthritis as well as in the inflammatory response against tumors. The receptors encoded by this gene mediate agonist-dependent calcium mobilization and inhibition of adenylyl cyclase.[1]

Animal studies

CCR2 deficient mice have been shown to develop an accelerated Alzheimer's-like pathology in comparison to wild type mice.[2][3] This is not the first time that immune function and inflammation have been linked to age-related cognitive decline (i.e. dementia).[4]

Clinical significance

In an observational study of gene expression in blood leukocytes in humans, Harries et al. found evidence of a relationship between expression of CCR2 and cognitive function (assessed using the mini-mental state examination, MMSE).[5] Higher CCR2 expression was associated with worse performance on the MMSE assessment of cognitive function. The same study found that CCR2 expression was also associated with cognitive decline over 9-years in a sub-analysis on inflammatory related transcripts only. Harries et al. suggest that CCR2 signaling may have a direct role in human cognition, partly because expression of CCR2 was associated with the ApoE haplotype (previously associated with Alzheimer's disease), but also because CCL2 is expressed at high concentrations in macrophages found in atherosclerotic plaques and in brain microglia.[2] The difference in observations between mice (CCR2 depletion causes cognitive decline) and humans (higher CCR2 associated with lower cognitive function) could be due to increased demand for macrophage activation during cognitive decline, associated with increased β-amyloid deposition (a core feature of Alzheimer's disease progression).

See also


  1. ^ a b c "Entrez Gene: CCR2 chemokine (C-C motif) receptor 2". 
  2. ^ a b El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (April 2007). "Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease". Nat. Med. 13 (4): 432–8. PMID 17351623. doi:10.1038/nm1555. 
  3. ^ Philipson O, Lord A, Gumucio A, O'Callaghan P, Lannfelt L, Nilsson LN (March 2010). "Animal models of amyloid-beta-related pathologies in Alzheimer's disease". FEBS J. 277 (6): 1389–409. PMID 20136653. doi:10.1111/j.1742-4658.2010.07564.x. 
  4. ^ Gorelick PB (October 2010). "Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials". Ann. N. Y. Acad. Sci. 1207: 155–62. PMID 20955439. doi:10.1111/j.1749-6632.2010.05726.x. 
  5. ^ Harries LW, Bradley-Smith RM, Llewellyn DJ, Pilling LC, Fellows A, Henley W, Hernandez D, Guralnik JM, Bandinelli S, Singleton A, Ferrucci L, Melzer D (May 2012). "Leukocyte CCR2 Expression Is Associated with Mini-Mental State Examination Score in Older Adults". Rejuvenation Res 15 (4): 395–404. PMID 22607625. doi:10.1089/rej.2011.1302. 

Further reading

  • Sozzani S; Introna M; Bernasconi S et al. (1997). "MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression". J. Leukoc. Biol. 62 (1): 30–3. PMID 9225989. 
  • Choe H; Martin KA; Farzan M et al. (1998). "Structural interactions between chemokine receptors, gp120 Env and CD4". Semin. Immunol. 10 (3): 249–57. PMID 9653051. doi:10.1006/smim.1998.0127. 
  • Cunningham AL; Li S; Juarez J et al. (2000). "The level of HIV infection of macrophages is determined by interaction of viral and host cell genotypes". J. Leukoc. Biol. 68 (3): 311–7. PMID 10985245. 
  • Ruibal-Ares BH; Belmonte L; Baré PC et al. (2004). "HIV-1 infection and chemokine receptor modulation". Curr. HIV Res. 2 (1): 39–50. PMID 15053339. doi:10.2174/1570162043484997. 
  • Yamagami S; Tokuda Y; Ishii K et al. (1994). "cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor". Biochem. Biophys. Res. Commun. 202 (2): 1156–62. PMID 8048929. doi:10.1006/bbrc.1994.2049. 
  • Charo IF; Myers SJ; Herman A et al. (1994). "Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails". Proc. Natl. Acad. Sci. U.S.A. 91 (7): 2752–6. PMC 43448. PMID 8146186. doi:10.1073/pnas.91.7.2752. 
  • Combadiere C; Ahuja SK; Van Damme J et al. (1996). "Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B". J. Biol. Chem. 270 (50): 29671–5. PMID 8530354. doi:10.1074/jbc.270.50.29671. 
  • Samson M, Soularue P, Vassart G, Parmentier M (1997). "The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3". Genomics 36 (3): 522–6. PMID 8884276. doi:10.1006/geno.1996.0498. 
  • Wong LM; Myers SJ; Tsou CL et al. (1997). "Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking". J. Biol. Chem. 272 (2): 1038–45. PMID 8995400. doi:10.1074/jbc.272.2.1038. 
  • Polentarutti N; Allavena P; Bianchi G et al. (1997). "IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences". J. Immunol. 158 (6): 2689–94. PMID 9058802. 
  • Gong X; Gong W; Kuhns DB et al. (1997). "Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors". J. Biol. Chem. 272 (18): 11682–5. PMID 9115216. doi:10.1074/jbc.272.18.11682. 
  • Daugherty BL, Springer MS (1997). "The beta-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) cluster within 285 kb on human chromosome 3p21". Genomics 41 (2): 294–5. PMID 9143512. doi:10.1006/geno.1997.4626. 
  • Berkhout TA; Sarau HM; Moores K et al. (1997). "Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B". J. Biol. Chem. 272 (26): 16404–13. PMID 9195948. doi:10.1074/jbc.272.26.16404. 
  • Smith MW; Dean M; Carrington M et al. (1997). "Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study". Science 277 (5328): 959–65. PMID 9252328. doi:10.1126/science.277.5328.959. 
  • Monteclaro FS, Charo IF (1997). "The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand". J. Biol. Chem. 272 (37): 23186–90. PMID 9287323. doi:10.1074/jbc.272.37.23186. 
  • Aragay AM; Mellado M; Frade JM et al. (1998). "Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2". Proc. Natl. Acad. Sci. U.S.A. 95 (6): 2985–90. PMC 19681. PMID 9501202. doi:10.1073/pnas.95.6.2985. 
  • Frade JM; Mellado M; del Real G et al. (1998). "Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells". J. Immunol. 159 (11): 5576–84. PMID 9548499. 
  • Mummidi S; Ahuja SS; Gonzalez E et al. (1999). "Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression". Nat. Med. 4 (7): 786–93. PMID 9662369. doi:10.1038/nm0798-786. 

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.